UAB compound designated orphan drug to advance towards a new treatment for spinal cord injury

by Universitat Autònoma de Barcelona (UAB)

The European Medicines Agency (EMA) has designated as an orphan drug a compound based on the bioactive lipid molecule Maresin-1 (MaR1), currently being investigated by a research team from the UAB for...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Genetics behind one of the main complica...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

A multicentre study led by researchers at the Hospital del Mar Researc...

Photos Stream